Healthcare >> Analyst Interviews >> December 18, 2000
ANDREW MILNE is a Vice President and Biotechnology Analyst at Dain
Rauscher Wessels, a division of Dain Rauscher, Incorporated, covering
biotechnology companies, including biopharmaceutical, specialty
pharmaceutical and drug delivery companies. He was previously associated
with Prudential Vector, Volpe Brown Whelan and BancBoston Robertson
Stephens. Mr. Milne received a BA in Physiology and Chemistry from
Michigan State University in East Lansing and a MS degree in
Biotechnology from John Hopkins University. Profile
biopharmaceutical companies over the next 12 months?
Mr. Milne: Biopharmaceuticals is an exciting area of development of
